Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Immunome, Inc. (IMNM) had Return on Equity of -13.56% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$2.93M |
|
$-41.64M |
|
-- |
|
$2.93M |
|
$47.56M |
|
$-44.64M |
|
$3.00M |
|
$-41.64M |
|
$-41.64M |
|
$-41.64M |
|
$-41.64M |
|
$-41.64M |
|
$-41.64M |
|
$-44.64M |
|
$-44.73M |
|
79.41M |
|
79.41M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$323.13M |
|
$10.95M |
|
$19.56M |
|
$342.69M |
|
$30.80M |
|
-- |
|
$4.77M |
|
$35.57M |
|
$307.13M |
|
$307.13M |
|
$307.13M |
|
86.96M |
|
| Cash Flow Statement Financials | |
$-53.05M |
|
$5.09M |
|
$162.23M |
|
$143.45M |
|
$257.71M |
|
$114.26M |
|
$5.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.49 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1525.49% |
|
-1525.49% |
|
-- |
|
-1423.10% |
|
-1423.10% |
|
$-56.72M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-13.56% |
-13.56% |
|
-12.15% |
|
-13.56% |
|
$3.53 |
|
$-0.71 |
|
$-0.67 |
|